SALIX PHARMACEUTICALS LTD - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 1, 2011

Attached files

file filename
10-K - FORM 10-K - SALIX PHARMACEUTICALS LTDd10k.htm
EX-3.1 - CERTIFICATE OF INCORPORATION, AS AMENDED - SALIX PHARMACEUTICALS LTDdex31.htm
EX-21.1 - SUBSIDIARIES OF REGISTRANT - SALIX PHARMACEUTICALS LTDdex211.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - SALIX PHARMACEUTICALS LTDdex322.htm
EX-31.2 - SECTION 302 CFO CERTIFCATION - SALIX PHARMACEUTICALS LTDdex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - SALIX PHARMACEUTICALS LTDdex311.htm
EX-10.79 - LICENSE AGREEMENT BETWEEN PHOTOCARE ASA AND SALIX PHARMACEUTICALS, INC. - SALIX PHARMACEUTICALS LTDdex1079.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - SALIX PHARMACEUTICALS LTDdex321.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (Nos. 333-110942 and 333-167112) and Form S-8 (Nos. 333-126685, 333-126290, 333-116675, 333-96771, 333-63604, 333-61497, 333-135268, 333-47586, 333-151658 and 333-160294) of Salix Pharmaceuticals, Ltd. of our report dated March 1, 2011 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Raleigh, North Carolina

March 1, 2011

Stock widget

Investing forum

SALIX PHARMACEUTICALS LTD Reports